KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Cash from Investing Activities: 2018-2025

Historic Cash from Investing Activities for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Sep 2025 value amounting to -$13.8 million.

  • Aurinia Pharmaceuticals' Cash from Investing Activities fell 30.27% to -$13.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.2 million, marking a year-over-year increase of 794.92%. This contributed to the annual value of $39.3 million for FY2024, which is 685.48% up from last year.
  • Aurinia Pharmaceuticals' Cash from Investing Activities amounted to -$13.8 million in Q3 2025, which was down 3.76% from -$13.3 million recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Cash from Investing Activities high stood at $49.2 million for Q1 2024, and its period low was -$67.2 million during Q1 2021.
  • In the last 3 years, Aurinia Pharmaceuticals' Cash from Investing Activities had a median value of -$6.3 million in 2023 and averaged $3.3 million.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Cash from Investing Activities spiked by 2,631.80% in 2022 and then tumbled by 588.69% in 2024.
  • Quarterly analysis of 5 years shows Aurinia Pharmaceuticals' Cash from Investing Activities stood at -$5.5 million in 2021, then skyrocketed by 45.00% to -$3.0 million in 2022, then slumped by 107.32% to -$6.3 million in 2023, then skyrocketed by 726.87% to $39.2 million in 2024, then plummeted by 30.27% to -$13.8 million in 2025.
  • Its Cash from Investing Activities was -$13.8 million in Q3 2025, compared to -$13.3 million in Q2 2025 and $31.0 million in Q1 2025.